SEATTLE--(BUSINESS WIRE)--Curi Bio, the industry leader in developing human stem cell-based platforms for drug discovery, is proud to announce the signing of a seven-year lease for a 13,942-square-foot space at BioMed Realty’s 201 Elliott Avenue West in Seattle. This strategic expansion will enable Curi Bio to expand its research and development efforts, advancing its mission to unlock critical human data that informs biopharmaceutical R&D decision-making..

西雅图--（商业新闻短讯）--Curi Bio是开发基于人类干细胞的药物发现平台的行业领导者，他自豪地宣布签署一份为期七年的租约，在西雅图Elliott Avenue West 201号BioMed Realty拥有13942平方英尺的空间。这一战略扩展将使库里生物公司能够扩大其研究和开发工作，推进其解锁关键人类数据的使命，为生物制药研发决策提供信息。。

“Our new space at 201 Elliott marks an exciting milestone in Curi Bio’s journey of innovation and sustained growth,” said Eric Swanson, VP of Operations at Curi Bio. “This site provides us with Class-A laboratory space designed to support the development and production of new disease models, biosystems, and data analysis tools.

库里生物运营副总裁埃里克·斯旺森（EricSwanson）表示：“我们在201 Elliott的新空间标志着库里生物创新和持续增长之旅中一个令人兴奋的里程碑。该网站为我们提供了A级实验室空间，旨在支持新疾病模型、生物系统和数据分析工具的开发和生产。

The efficient layout ensures that we can remain agile while offering ample room for growth and fostering the cross-functional collaboration that has driven our success. With floor-to-ceiling windows overlooking Puget Sound, this exceptional space not only creates a welcoming work environment for our talented team, but also serves as a compelling setting for clients and collaborators to engage directly with our technology and team.”.

高效的布局确保了我们能够保持敏捷，同时提供了充足的增长空间，并促进了推动我们成功的跨职能合作。从地板到天花板的窗户俯瞰普吉特湾，这一特殊的空间不仅为我们有才能的团队创造了一个受欢迎的工作环境，而且为客户和合作者提供了一个引人注目的环境，可以直接与我们的技术和团队打交道。”。

Curi Bio’s expansion comes at a pivotal time as the company continues to push the boundaries of preclinical translational research. The company’s integrated human cell-based platforms empower its customers with highly predictive functional data that offer valuable insights to significantly reduce the time and cost of drug development.

居里生物的扩张正值关键时刻，因为该公司继续推进临床前转化研究的界限。该公司基于人体细胞的集成平台为客户提供了高度预测性的功能数据，这些数据提供了有价值的见解，可以显着减少药物开发的时间和成本。

The company’s new global headquarters will support its R&D, hardware manufacturing, cell and culture media production, as well as its therapeutic assays services, data science, and software development teams..

该公司新的全球总部将支持其研发、硬件制造、细胞和培养基生产，以及其治疗分析服务、数据科学和软件开发团队。。

The new space at 201 Elliott Avenue West offers an array of amenities that align with Curi Bio’s commitment to innovation and employee well-being. Overlooking Elliott Bay, the property features a fitness center, a courtyard, a newly renovated cafe, and reserved underground parking. Its proximity to Myrtle Edwards Park and Olympic Sculpture Park, as well as numerous retail and dining options, makes it a prime location for the next phase of Curi Bio’s growth..

位于Elliott Avenue West 201号的新空间提供了一系列便利设施，符合Curi Bio对创新和员工福利的承诺。该酒店俯瞰埃利奥特湾，拥有健身中心、庭院、新装修的咖啡馆和预留的地下停车场。它靠近桃金娘爱德华兹公园和奥林匹克雕塑公园，以及众多的零售和餐饮选择，使其成为居里生物下一阶段发展的最佳地点。。

BioMed Realty’s 201 Elliott Avenue West is one of eight properties the company operates in the Seattle area, providing critical infrastructure and flexible, scalable solutions tailored to the unique needs of life sciences companies. “The BMR team has been a joy to work with,” Swanson said. “Their expertise and deep experience were key factors in selecting this site, and it’s already proving to be invaluable as we take this tremendous next step in our journey.” Curi Bio aims to move into the new space by early 2025..

BioMed Realty位于Elliott Avenue West 201号，是该公司在西雅图地区运营的八处房产之一，提供关键的基础设施和灵活、可扩展的解决方案，以满足生命科学公司的独特需求。斯旺森说：“与BMR团队合作是一件愉快的事。”。“他们的专业知识和丰富的经验是选择这个网站的关键因素，随着我们在旅程中迈出这一巨大的下一步，它已经被证明是无价的。”库里生物公司的目标是在2025年初进入新的空间。。

“We’re building palpable momentum across all functions of our team,” Swanson continued. “We’ve achieved significant revenue growth and new customer adoption despite the challenging macroeconomic climate in our industry. The move to 201 Elliott will help us amplify this momentum, providing us with the ideal environment to foster innovation and accelerate our mission.

斯旺森继续说：“我们正在团队的所有职能部门建立明显的势头。”。“尽管我们的行业面临严峻的宏观经济环境，但我们取得了显著的收入增长和新客户的采用率。加入201 Elliott将有助于我们扩大这一势头，为我们提供理想的环境，以促进创新并加速我们的使命。

I’m looking forward to seeing what Curi Bio will accomplish in our new home.”.

我期待着看到居里生物将在我们的新家里取得什么成就。”。

About Curi Bio

关于库里生物

Curi Bio unlocks novel workflows and delivers functional human data to inform biopharmaceutical R&D decision-making. Through an integrated platform featuring advanced 3D tissue models of disease, biosystems enabling clinically relevant functional analyses, and AI/ML-enabled insights, Curi Bio melds functional and analytical assessments for drug safety, efficacy, and potency.

。通过一个集成平台，该平台具有先进的疾病3D组织模型，支持临床相关功能分析的生物系统以及支持AI/ML的见解，Curi Bio-melds对药物安全性，功效和效力进行了功能和分析评估。

By offering leading global pharmaceutical end users an integrated preclinical platform along with highly predictive human stem cell tissue models to generate clinically-relevant data, Curi Bio is bridging the gap between preclinical R&D and clinical outcomes, accelerating the discovery and development of safer, more effective medicines..

通过为全球领先的制药最终用户提供一个集成的临床前平台以及高度预测性的人类干细胞组织模型来生成临床相关数据，Curi Bio正在弥合临床前研发与临床结果之间的差距，加速发现和开发更安全，更有效的药物。。

For more information, please visit www.curibio.com.

欲了解更多信息，请访问www.curibio.com。